Erudio Healtherudio.com
Drug
Nogapendekin alfa inbakicept trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying nogapendekin alfa inbakicept: QUILT-3.055. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| QUILT-3.055 NCT03228667 · ImmunityBio, Inc. | cancer previously treated with immune checkpoint inhibitors | Phase 2 | 91 | 13 | Focused | Nov 20, 2026 | Preview |